It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Peptide hormones and neuropeptides are signaling molecules that control diverse aspects of mammalian homeostasis and physiology. Here we provide evidence for the endogenous presence of a sequence diverse class of blood-borne peptides that we call “capped peptides.” Capped peptides are fragments of secreted proteins and defined by the presence of two post-translational modifications – N-terminal pyroglutamylation and C-terminal amidation – which function as chemical “caps” of the intervening sequence. Capped peptides share many regulatory characteristics in common with that of other signaling peptides, including dynamic physiologic regulation. One capped peptide, CAP-TAC1, is a tachykinin neuropeptide-like molecule and a nanomolar agonist of mammalian tachykinin receptors. A second capped peptide, CAP-GDF15, is a 12-mer peptide cleaved from the prepropeptide region of full-length GDF15 that, like the canonical GDF15 hormone, also reduces food intake and body weight. Capped peptides are a potentially large class of signaling molecules with potential to broadly regulate cell-cell communication in mammalian physiology.
The cells of our bodies use chemical signals to talk with each other. Here the authors describe a class of signaling molecules called “capped peptides” that may mediate cell-cell communication. Unlike other peptides, capped peptides have unique chemical modifications which make them potentially more active and stable.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 Stanford University School of Medicine, Department of Pathology, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956); Stanford University, Department of Chemistry, Stanford, USA (GRID:grid.168010.e) (ISNI:0000 0004 1936 8956); Stanford University, Sarafan ChEM-H, Stanford, USA (GRID:grid.168010.e) (ISNI:0000 0004 1936 8956); Stanford University, Wu Tsai Human Performance Alliance, Stanford, USA (GRID:grid.168010.e) (ISNI:0000 0004 1936 8956)
2 Stanford University School of Medicine, Department of Pathology, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956); Stanford University, Sarafan ChEM-H, Stanford, USA (GRID:grid.168010.e) (ISNI:0000 0004 1936 8956)
3 Stanford University School of Medicine, Department of Pathology, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956)
4 Stanford University School of Medicine, Department of Pathology, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956); Stanford University, Sarafan ChEM-H, Stanford, USA (GRID:grid.168010.e) (ISNI:0000 0004 1936 8956); Stanford University, Department of Biology, Stanford, USA (GRID:grid.168010.e) (ISNI:0000 0004 1936 8956)
5 Stanford University School of Medicine, Department of Pathology, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956); Stanford University, Sarafan ChEM-H, Stanford, USA (GRID:grid.168010.e) (ISNI:0000 0004 1936 8956); Stanford University, Wu Tsai Human Performance Alliance, Stanford, USA (GRID:grid.168010.e) (ISNI:0000 0004 1936 8956)
6 Stanford University School of Medicine, Department of Pathology, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956); Stanford University, Stanford Diabetes Research Center, Stanford, USA (GRID:grid.168010.e) (ISNI:0000 0004 1936 8956)
7 Stanford University School of Medicine, Department of Pathology, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956); Stanford University, Department of Chemistry, Stanford, USA (GRID:grid.168010.e) (ISNI:0000 0004 1936 8956); Stanford University, Sarafan ChEM-H, Stanford, USA (GRID:grid.168010.e) (ISNI:0000 0004 1936 8956); Stanford University, Wu Tsai Human Performance Alliance, Stanford, USA (GRID:grid.168010.e) (ISNI:0000 0004 1936 8956); Stanford University, Stanford Diabetes Research Center, Stanford, USA (GRID:grid.168010.e) (ISNI:0000 0004 1936 8956)